ABSTRACT
The ever-increasing demands on the performance of pharmaceutical formulations with respect to, e.g., storage stability, increased dosage levels, greater bioavailability, fewer side effects, controlled release, and biological response (e.g., tissue distribution) constitute the main motivation for drug delivery research. In the last few decades, this research has resulted in the development of, e.g., parenteral emulsions, liposomes with improved circulation in the bloodstream, cyclodextrins, and lipoprotein mimics for cancer therapeutics.
